| Literature DB >> 29764958 |
Charlotte Jackson1, Jo Southern2, Ajit Lalvani3, Francis Drobniewski3,4, Chris J Griffiths5, Marc Lipman6,7, Graham H Bothamley8, Jonathan J Deeks9,10, Ambreen Imran2, Onn Min Kon11,12, Sithembinkosi Mpofu2, Vladyslav Nikolayevskyy3,4,13, Melanie Rees-Roberts3, Alice Sitch9, Saranya Sridhar3, Chuen-Yan Tsou4, Hilary Whitworth3,14, Ibrahim Abubakar1.
Abstract
We conducted a cross-sectional analysis of baseline data from a UK cohort study which enrolled participants at risk of latent tuberculosis infection (LTBI, defined as a positive result for either of the two interferon gamma release assays). Binomial regression with a log link was used to estimate crude and adjusted prevalence ratios (PRs) and 95% CIs for the relationship between diabetes mellitus (DM) and LTBI. Adjusted for age, sex, ethnicity, body mass index and the presence of other immunocompromising conditions, DM was associated with a 15% higher prevalence of LTBI (adjusted PR=1.15, 95% CI 1.02 to 1.30, p=0.025). TRIAL REGISTRATION NUMBER: PREDICT is registered on clinicaltrials.gov (NCT01162265). © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2019. All rights reserved. No commercial use is permitted unless otherwise expressly granted.Entities:
Keywords: clinical epidemiology; tuberculosis
Mesh:
Year: 2018 PMID: 29764958 DOI: 10.1136/thoraxjnl-2017-211124
Source DB: PubMed Journal: Thorax ISSN: 0040-6376 Impact factor: 9.139